Cargando…
Tamoxifen Treatment of Breast Cancer Cells: Impact on Hedgehog/GLI1 Signaling
The selective estrogen receptor (ER) modulator tamoxifen (TAM) has become the standard therapy for the treatment of ER+ breast cancer patients. Despite the obvious benefits of TAM, a proportion of patients acquire resistance to treatment, and this is a significant clinical problem. Consequently, the...
Autores principales: | Villegas, Victoria E., Rondón-Lagos, Milena, Annaratone, Laura, Castellano, Isabella, Grismaldo, Adriana, Sapino, Anna, Zaphiropoulos, Peter G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813171/ https://www.ncbi.nlm.nih.gov/pubmed/26927093 http://dx.doi.org/10.3390/ijms17030308 |
Ejemplares similares
-
Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes
por: Rondón-Lagos, Milena, et al.
Publicado: (2016) -
Tamoxifen Resistance: Emerging Molecular Targets
por: Rondón-Lagos, Milena, et al.
Publicado: (2016) -
AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors
por: Rangel, Nelson, et al.
Publicado: (2020) -
Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines
por: Rangel, Nelson, et al.
Publicado: (2017) -
RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling
por: Shimokawa, Takashi, et al.
Publicado: (2013)